Oxeltra 10mg modified-release tablets
BNF presentation 0407020ADBLAFAF within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBLAFAF
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
7,220
NHS spend (£)
£38,524.35
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,014 |
| February 2025 | 12 |
| December 2024 | 293 |
| November 2024 | 1,123 |
| October 2024 | 1,137 |
| September 2024 | 7 |
| August 2024 | 93 |
| July 2024 | 926 |
| May 2024 | 292 |
| July 2021 | 368 |
| June 2021 | 286 |
| December 2020 | 761 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 53 | No data available |
| Unknown pharmacy | 50 | No data available |
| Unknown pharmacy | 48 | No data available |
| Unknown pharmacy | 46 | No data available |
| Unknown pharmacy | 43 | No data available |
| Unknown pharmacy | 40 | No data available |
| Unknown pharmacy | 38 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 35 | No data available |